Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! It is not uncommon to see companies perform well in the years after insiders ...

Immuron Limited has announced strong progress in several key projects, including expected sales exceeding A$7 million this financial year, a significant increase from last year’s A$4.9 million. The ...

NEW YORK CITY, NY / ACCESS Newswire / April 22, 2026 / Emerging Growth Research today released a Flash Report on ...

The day traders are back at it, chasing stocks on news with very few thoughts about what the fundamentals may be if the good news pans out. In day trading, that just doesn’t matter because a trade is ...

(RTTNews) - Shares of Immuron Ltd. (IMRN) are rallying over 48% in pre-market today, after the company announced that it has partnered with CSIRO to produce a new oral therapeutic for clinical ...

MELBOURNE, Australia, March 07, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to announce the ...

MELBOURNE, Australia, May 31, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, advises that Dr Roger Aston has ...

MELBOURNE, Australia, March 03, 2020 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral ...

Immuron Limited reports record sales of Travelan®, reaching AUD$7.3 million, up 49% annually, driven by strong growth in Australia and North America. Immuron Limited has reported significant growth in ...

Q3 sales AUD$0.5 million up 1% on prior comparative period (pcp) YTD Mar 2026 sales AUD$1.3 million up 10% on prior comparative period (pcp) MELBOURNE, Australia, April 17, 2026 (GLOBE NEWSWIRE)-- ...